Product image of Meropenem Xiromed (Meropenem) supplied by GNH India

Meropenem Xiromed

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Xiromed (Meropenem)

Meropenem, the active ingredient in Meropenem Xiromed, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections in hospitalized patients, including those caused by multidrug‑resistant organisms.

GNH India supplies Meropenem Xiromed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Medical Valley Invest Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem used for serious infections caused by susceptible bacteria.

  • Complicated intra‑abdominal infection: provides coverage against Gram‑negative, Gram‑positive and anaerobic pathogens.
  • Complicated urinary tract infection: eradicates resistant Enterobacteriaceae and Pseudomonas species.
  • Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: achieves high lung tissue concentrations.
  • Bacterial sepsis and meningitis: penetrates the bloodstream and cerebrospinal fluid to treat systemic infections.

How It Works

  • Meropenem binds to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and bacterial death. Its high affinity for a broad range of PBPs accounts for activity against many Gram‑negative, Gram‑positive and anaerobic organisms, including many resistant strains.

Side Effects

Adverse reactions may occur with meropenem therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Vomiting: occasional emesis during infusion.
  • Diarrhea: may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Rash: mild skin erythema.
  • Infusion site phlebitis: local irritation at IV site.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disorders.
  • Clostridioides difficile‑associated diarrhea: severe colitis risk.
  • Anaphylaxis: acute hypersensitivity reaction.
  • Renal toxicity: elevated creatinine levels.
  • Hepatic enzyme elevation: transient transaminase increase.
  • Severe neutropenia: marked reduction in white blood cells.

Precautions & Warnings

Meropenem should be used with consideration of patient‑specific factors.

  • Renal function: adjust dose in patients with impaired renal function.
  • Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams.
  • Seizure risk: monitor patients with a history of CNS disorders.
  • Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
  • Concomitant valproic acid: monitor serum valproate levels as they may decrease.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Meropenem may interact with other medicines; clinical monitoring is advised.

Major Interactions (Avoid)

  • Valproic acid: meropenem can significantly reduce serum valproate concentrations.
  • Probenecid: may increase meropenem plasma levels, raising toxicity risk.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: combined use may heighten nephrotoxicity.
  • Aminoglycosides: additive renal toxicity potential.
  • Warfarin: meropenem may potentiate anticoagulant effect, requiring INR monitoring.

Frequently Asked Questions

Meropenem Xiromed is indicated for serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia (including ventilator‑associated pneumonia), and severe sepsis or meningitis caused by susceptible organisms.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This leads to weakened cell walls and bacterial lysis, providing broad‑spectrum activity against many Gram‑negative, Gram‑positive and anaerobic bacteria.

The dosage of Meropenem Xiromed is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and local antimicrobial guidelines. Only a qualified healthcare professional should set the dosing regimen.

Safety data in pregnancy and lactation are limited. Meropenem should be used only if the expected benefit to the mother outweighs any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Meropenem shares the broad‑spectrum activity of the carbapenem class but offers a slightly lower risk of seizure activity compared with imipenem. It is stable against many β‑lactamases and is often preferred for infections caused by resistant Gram‑negative organisms.

Meropenem Xiromed should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen. Once reconstituted, the solution should be used within the time frame specified in the product labeling and kept at controlled room temperature if required.

Meropenem Xiromed is supplied as a sterile powder for intravenous infusion. It is reconstituted with the appropriate diluent and administered by slow IV infusion over 15–30 minutes, according to the prescribing clinician’s instructions.

Serious risks include the potential for seizures, especially in patients with renal impairment or pre‑existing CNS disorders, severe allergic reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis, which can be life‑threatening.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics should not receive Meropenem Xiromed. Caution is also advised for individuals with a history of seizures or severe renal impairment, where alternative therapy may be considered.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT